SuanNutra to Acquire Specialty Natural Ingredients Businesses From IFF

SuanNutra, a portfolio company of Carbyne Equity Partners, has signed an agreement to acquire a portfolio of specialty natural ingredients businesses from IFF.¹

The businesses being acquired will merge into SuanNutra's existing operations, and the transaction is expected to close by the end of 2026, subject to regulatory clearances and other customary closing conditions.

For manufacturers evaluating suppliers, the deal signals continued consolidation in a segment of the ingredient industry that has already been shifting away from synthetic inputs.

"Clinically supported branded ingredients are where this industry is heading, proven actives with the science to stand behind them," said Yoni Glickman, non-executive chairman of SuanNutra, in the companies' announcement.¹ "The move from artificial colors and preservatives to natural, scientifically substantiated ingredients is reshaping the food and health industries faster than ever."

What Is the Structure and Scope of the Transaction?

The acquired businesses bring branded ingredients with clinical support, botanical extraction facilities the company will own directly, and fermentation-derived vitamins and minerals, alongside plant-derived colors, antioxidants, and flavors.

The combined manufacturing footprint includes botanical extraction sites in Spain, Slovenia, and Peru, along with fermentation operations in the United States. Once merged, the enlarged group is expected to employ roughly 700 people serving more than 1,200 customers across more than 60 countries.

The companies did not disclose the purchase price, but both parties did indicate that customers of the acquired businesses will continue to be served without interruption during the transition, and that the combined group intends to continue investing in commercial capability, research and development, and innovation.

Why Are Natural Colors and Clean-Label Ingredients Central to This Deal?

The acquisition places particular emphasis on natural colors, antioxidants, and flavors, categories that have drawn sustained manufacturer interest as synthetic dyes face increasing scrutiny. In the United States, the FDA revised its policy earlier in 2026 to allow "no artificial colors" labeling claims under updated conditions, a step regulators described as part of a broader transition away from petroleum-based synthetic dyes.²

That kind of regulatory movement has coincided with steady growth in demand for plant-derived pigments, while 1 industry analysis valued the global natural food colors market at approximately $2.3 billion in 2025, with continued growth projected through the early 2030s, driven in part by consumer associations between synthetic dyes and health concerns such as hyperactivity in children.³

SuanNutra's stated strategy, which it refers to internally as "Visible Health," centers on clinically backed ingredients paired with the formulation capabilities needed to help brands act on clean-label positioning rather than simply market it.

How Should Manufacturers Interpret This Consolidation?

Acquisitions that combine branded, clinically supported ingredients with manufacturing capacity are not unusual in a market where sourcing concentration and formulation complexity both remain persistent challenges.

What is less certain, at this stage, is how integration will affect lead times, technical support, or pricing for customers of the legacy IFF businesses during the transition period. The companies' statements emphasize continuity of service, but transitions of this scale typically involve some operational adjustment as systems, contracts, and account relationships are consolidated.

It is also worth noting that the announcement is a forward-looking statement of intent rather than a completed transaction. The deal remains subject to regulatory clearance, and terms such as valuation were not disclosed, which limits how precisely manufacturers can assess the deal's competitive implications before it closes.

References

1. SuanNutra. SuanNutra, a Carbyne Equity Partners portfolio company, expands product portfolio with specialty natural ingredients businesses from IFF. July 20, 2026. Accessed July 20, 2026. https://www.prnewswire.com/news-releases/suannutra-a-carbyne-equity-partners-portfolio-company-expands-product-portfolio-with-specialty-natural-ingredients-businesses-from-iff-302829554.html

2. US Food and Drug Administration. FDA takes new approach to "No Artificial Colors" claims. Press announcement. February 5, 2026. Accessed July 20, 2026. https://www.fda.gov/news-events/press-announcements/fda-takes-new-approach-no-artificial-colors-claims

3. Grand View Research. Natural food colors market, 2026-2033. June 2026. Accessed July 20, 2026. https://www.grandviewresearch.com/industry-analysis/natural-food-colors-market